Registration number: 07450536

Probus Surgery Limited

Contents

Company Information	1
Balance Sheet	2 to 3
Notes to the Unaudited Financial Statements	4 to 9

Probus Surgery Limited

Company Information

Directors

Dr G Lin Sin Cho Dr R Murthy Dr K Smithson Dr G E Moon Mr J S Casey

Registered office

The Surgery Tregony Road Probus Cornwall TR2 4JZ

Probus Surgery Limited

(Registration number: 07450536)
Balance Sheet as at 31 March 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	169,918	171,184
Investments	5	200	200
		170,118	171,384
Current assets
Stocks		11,842	11,842
Debtors	6	431,712	409,754
Cash at bank and in hand		905,886	1,051,563
		1,349,440	1,473,159
Creditors: Amounts falling due within one year	7	(594,844)	(541,192)
Net current assets		754,596	931,967
Total assets less current liabilities		924,714	1,103,351
Provisions for liabilities		(41,737)	(41,891)
Net assets		882,977	1,061,460
Capital and reserves
Called up share capital	8	95	95
Retained earnings		882,882	1,061,365
Shareholders' funds		882,977	1,061,460

Probus Surgery Limited

(Registration number: 07450536)
Balance Sheet as at 31 March 2026

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 19 July 2026 and signed on its behalf by:
 

......................................... Dr G Lin Sin Cho Director

Probus Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
The Surgery
Tregony Road
Probus
Cornwall
TR2 4JZ

These financial statements were authorised for issue by the Board on 19 July 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Disclosure of long or short period

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Probus Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and machinery	20% reducing balance
Fixtures and fittings	20% reducing balance
Computer equipment	33% reducing balance

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Probus Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 41 (2025 - 42).

Probus Surgery Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

4	Tangible assets

	Fixtures and fittings £	Plant and machinery £	Office equipment £	Total £
Cost or valuation
At 1 April 2025	60,842	406,300	146,093	613,235
Additions	115	25,407	24,339	49,861
At 31 March 2026	60,957	431,707	170,432	663,096
Depreciation
At 1 April 2025	31,821	292,994	117,236	442,051
Charge for the year	5,827	27,746	17,554	51,127
At 31 March 2026	37,648	320,740	134,790	493,178
Carrying amount
At 31 March 2026	23,309	110,967	35,642	169,918
At 31 March 2025	29,021	113,306	28,857	171,184

5	Investments

	2026 £	2025 £
Investments in subsidiaries	200	200